Skip to content

Study on Treatment of Chronic Fatigue with MSC-CM

Study on the Treatment of Chronic Fatigue Using Human-Derived Mesenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051240143
Enrollment
Unknown
Registered
2024-10-02
Start date
2024-10-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue

Interventions

None listed

Sponsors

Atsutomo Morishima
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Those who have not achieved satisfactory therapeutic effects with standard treatments. 2. Those who do not wish to use existing medications due to concerns about side effects and are deemed suitable for treatment with culture supernatant by their physician.. The patient selection criteria are as follows: Patients meeting the following criteria will be considered eligible: 1. Individuals aged 18 and above. 2. Individuals with normal decision-making capacity. 3. Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Anyone who meets any of the following conditions will be excluded: 1. Users of narcotics or stimulants. 2. Those deemed unsuitable by the attending physician.

Design outcomes

Primary

MeasureTime frame
1. atigue Visual Analogue Scale (VAS) 2.Chalder Fatigue Scale

Secondary

MeasureTime frame
subjective symptoms, etc.

Contacts

Public ContactMorishima Atsutomo

Omotesando Wellness Clinic

atsu5426@yahoo.co.jp+81-359626485

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026